Banach M - Search Results

1

Personalized management of dyslipidemias in patients with diabetes-it is time for a new approach (2022).

Banach M, Surma S, Reiner Z, Katsiki N, Penson PE, Fras Z, Sahebkar A, Paneni F, Rizzo M, Kastelein J. Banach M, et al. Cardiovasc Diabetol. 2022 Nov 28;21(1):263. doi: 10.1186/s12933-022-01684-5. Cardiovasc Diabetol. 2022. PMID: 36443827 Free PMC article. Review.

2

Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels.

Katsiki N, Mikhailidis DP, Banach M. Katsiki N, et al. Among authors: banach m. J Hypertens. 2011 Dec;29(12):2493-4; author reply 2494. doi: 10.1097/HJH.0b013e32834c7bc9. J Hypertens. 2011. PMID: 22075958 No abstract available.

3

The effects of statins on blood pressure: current knowledge and future perspectives.

Rizzo M, Montalto G, Banach M. Rizzo M, et al. Among authors: banach m. Arch Med Sci. 2012 Feb 29;8(1):1-3. doi: 10.5114/aoms.2012.27270. Arch Med Sci. 2012. PMID: 22457664 Free PMC article. No abstract available.

4

Lipid-lowering therapies and achievement of LDL-cholesterol targets.

Rizzo M, Banach M, Montalto G, Mikhailidis DP. Rizzo M, et al. Among authors: banach m. Arch Med Sci. 2012 Sep 8;8(4):598-600. doi: 10.5114/aoms.2012.30281. Arch Med Sci. 2012. PMID: 23056067 Free PMC article. No abstract available.

5

Predictors of insulin resistance in patients with obesity: a pilot study.

Stepien M, Stepien A, Wlazel RN, Paradowski M, Rizzo M, Banach M, Rysz J. Stepien M, et al. Among authors: banach m. Angiology. 2014 Jan;65(1):22-30. doi: 10.1177/0003319712468291. Epub 2012 Dec 23. Angiology. 2014. PMID: 23267236

6

Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance.

Banach M, Malodobra-Mazur M, Gluba A, Katsiki N, Rysz J, Dobrzyn A. Banach M, et al. Curr Pharm Des. 2013;19(27):4904-12. doi: 10.2174/1381612811319270014. Curr Pharm Des. 2013. PMID: 23278491 Review.

7

PCSK9 inhibition - a novel mechanism to treat lipid disorders?

Banach M, Rizzo M, Obradovic M, Montalto G, Rysz J, Mikhailidis DP, Isenovic ER. Banach M, et al. Curr Pharm Des. 2013;19(21):3869-77. doi: 10.2174/13816128113199990303. Curr Pharm Des. 2013. PMID: 23286435 Review.

8

Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia?

Rizzo M, Barylski M, Rizvi AA, Montalto G, Mikhailidis DP, Banach M. Rizzo M, et al. Among authors: banach m. Curr Pharm Des. 2013;19(21):3858-68. doi: 10.2174/13816128113199990324. Curr Pharm Des. 2013. PMID: 23286436 Review.

9

The role of fibrate treatment in dyslipidemia: an overview.

Katsiki N, Nikolic D, Montalto G, Banach M, Mikhailidis DP, Rizzo M. Katsiki N, et al. Among authors: banach m. Curr Pharm Des. 2013;19(17):3124-31. doi: 10.2174/1381612811319170020. Curr Pharm Des. 2013. PMID: 23317397 Review.

10

Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials.

Nikolic D, Nikfar S, Salari P, Rizzo M, Ray KK, Pencina MJ, Mikhailidis DP, Toth PP, Nicholls SJ, Rysz J, Abdollahi M, Banach M; Lipid and Blood Pressure Meta-Analysis Collaboration Group. Nikolic D, et al. Among authors: banach m. Curr Med Res Opin. 2013 May;29(5):435-51. doi: 10.1185/03007995.2013.779237. Epub 2013 Mar 11. Curr Med Res Opin. 2013. PMID: 23427811 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,238 results

Search Page